AVIDITY BIOSCIENCES

Serial Number 88808600
Registration 7055715
700

Registration Progress

Application Filed
Feb 24, 2020
Under Examination
Aug 25, 2020
Approved for Publication
Jun 30, 2020
Published for Opposition
Jun 30, 2020
Registered
May 16, 2023

Trademark Image

AVIDITY BIOSCIENCES

Basic Information

Serial Number
88808600
Registration Number
7055715
Filing Date
February 24, 2020
Registration Date
May 16, 2023
Published for Opposition
June 30, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 16, 2023
Registration
Registered
Classes
005 042

Rights Holder

Avidity Biosciences, Inc.

03
Address
10578 Science Drive, Suite 125
San Diego, CA 92121

Ownership History

Avidity Biosciences, Inc.

Original Applicant
03
La Jolla, CA

Avidity Biosciences, Inc.

Owner at Publication
03
San Diego, CA

Avidity Biosciences, Inc.

Original Registrant
03
San Diego, CA

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

Next Deadline
1385 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-16)
Due Date
May 16, 2029
Grace Period Ends
November 16, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
May 16, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 16, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 13, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 12, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 4, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jan 30, 2023 CNFR W SU - FINAL REFUSAL - WRITTEN Loading...
Jan 30, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 30, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Dec 31, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 31, 2022 ALIE A ASSIGNED TO LIE Loading...
Dec 31, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 4, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 15, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 15, 2022 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Aug 24, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 23, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 23, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 23, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 15, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 15, 2022 IUAF S USE AMENDMENT FILED Loading...
Aug 15, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 15, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 18, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 18, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 18, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 18, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 18, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 14, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 28, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 26, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 26, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 26, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 27, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 25, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 25, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 25, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 25, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 30, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 30, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 10, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 28, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 28, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 28, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 28, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...

Detailed Classifications

Class 005
Biological, medicinal and pharmaceutical preparations, namely, oligonucleotide-based therapeutics for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere: Nov 4, 2021
First Use in Commerce: Nov 4, 2021
Class 042
providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
First Use Anywhere: Nov 4, 2021
First Use in Commerce: Nov 4, 2021

Additional Information

Design Mark
The mark consists of the wording "AVIDITY" in an all-caps font where the "A" is formed by a down-facing angle. The wording "BIOSCIENCES" appears below in a smaller all-caps font. To the left of the wording is a highly stylized design of two curved ribbons forming a diamond or partial double-helix shape.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"